Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. CareRx Corporation
  6. News
  7. Summary
    CRRX   CA14173C1059

CARERX CORPORATION

(CRRX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CareRx : Expands Existing Contract with Seniors Home Operator, Adding 1,500 Beds

09/14/2021 | 07:01am EST

TORONTO, Sept. 14, 2021 /CNW/ - CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, announced today that it has expanded its existing contract with an Ontario-based seniors home operator that is expected to add approximately 1,500 new retirement and long-term care residents in 19 seniors housing communities. The new beds are expected to transition to CareRx at the beginning of the fourth quarter of 2021, and will be serviced through CareRx's existing infrastructure.

"The decision by our customer to consolidate from using multiple pharmacy service providers to using CareRx exclusively is a testament to our compelling value proposition, service differentiation, and focus on resident safety and wellbeing," said David Murphy, President and Chief Executive Officer of CareRx. "This win, combined with our recent M&A activity, puts us one step closer to achieving our target of 100,000 beds serviced."

About CareRx Corporation

CareRx is Canada's leading provider of pharmacy services to seniors living communities. We serve over 92,000 residents in over 1,500 seniors and other congregate care communities (long-term care homes, retirement homes, assisted living facilities, and group homes). We are a national organization with a large network of pharmacy fulfillment centres strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimes. We take an active role in working with our home operator partners to promote resident health, staff education, and medication system quality and efficiency.

Forward-Looking Statements

This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. These forward-looking statements include, among others, statements regarding the Company's business strategy, plans and other expectations, beliefs, goals, objectives, information and statements about possible future events. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "anticipate" or similar expressions suggesting future outcomes or events. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management.

Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by such statements. Factors that could cause such differences include the Company's exposure to and reliance on government regulation and funding, the Company's liquidity and capital requirements, exposure to epidemic or pandemic outbreak, acquisitions and integrations undertaken by the Company, the highly competitive nature of the Company's industry, reliance on contracts with key customers and other risk factors described from time to time in the reports and disclosure documents filed by the Company with Canadian securities regulatory agencies and commissions. These and other factors should be considered carefully and readers should not place undue reliance on the Company's forward-looking statements. As a result of the foregoing and other factors, no assurance can be given as to any such future results, levels of activity or achievements and neither the Company nor any other person assumes responsibility for the accuracy and completeness of these forward-looking statements. The factors underlying current expectations are dynamic and subject to change.

SOURCE CareRx Corporation

© Canada Newswire, source Canada Newswire English

All news about CARERX CORPORATION
11/29CARERX TO PRESENT AT THE DESJARDINS : 30 p.m. et
AQ
11/10CARERX Q3-21 EARNINGS CALL – N : 00am EST | Earnings Call Slides
PU
11/09CareRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended..
CI
11/09Earnings Flash (CRRX.TO) CARERX CORPORATION Posts Q3 Loss C$0.11
MT
11/09CareRx Reports 56% Year-Over-Year Growth in Revenue and 79% Year-Over-Year Growth in Ad..
AQ
11/01CARERX CORPORATION TO HOST THIRD QUA : 00 a.m. ET
AQ
09/30CARERX AND ACEAGE ANNOUNCE RESULTS O : Demonstrates 97% Medication Compliance
AQ
09/30CARERX AND ACEAGE ANNOUNCE RESULTS O : Demonstrates 97% Medication Compliance
CI
09/21CARERX : Expands Partnership with Think Research to Deliver Virtual Care Telemedicine Acro..
AQ
09/21THINK RESEARCH : Partners With CareRx, Chartwell, on Telemedicine Service for Seniors' Res..
MT
More news
Analyst Recommendations on CARERX CORPORATION
More recommendations
Financials
Sales 2021 257 M 200 M 200 M
Net income 2021 -25,1 M -19,5 M -19,5 M
Net Debt 2021 - - -
P/E ratio 2021 -7,86x
Yield 2021 -
Capitalization 221 M 173 M 172 M
Capi. / Sales 2021 0,86x
EV / Sales 2022 0,58x
Nbr of Employees 850
Free-Float 76,9%
Chart CARERX CORPORATION
Duration : Period :
CareRx Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARERX CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 5,07 CAD
Average target price 9,03 CAD
Spread / Average Target 78,1%
EPS Revisions
Managers and Directors
David Murphy President, Chief Executive Officer & Director
Andrew Mok Chief Financial Officer
Jack Shevel Chairman-Emeritus
Kevin William Dalton Chairman
Jeff May Chief Operating Officer
Sector and Competitors